Ozempic Lawsuit: What You Need To Know (2024)
Ozempic (semaglutide) is a medication that improves blood sugar levels in those with type 2 diabetes. Manufactured by pharmaceutical company Novo Nordisk, Ozempic was approved by the FDA in 2017 and belongs to a class of drugs known as GLP1 receptor agonists. By mimicking the hormone GLP-1, Ozempic helps stimulate insulin release when blood sugar
Ozempic Lawsuit: What You Need To Know (2024) Read More »




